CAMBRIDGE NUTRITIONAL SCIENCES PLC Logo

CAMBRIDGE NUTRITIONAL SCIENCES PLC

Develops and manufactures diagnostic tests for food sensitivity and gut health.

CNSL | IL

Overview

Corporate Details

ISIN(s):
GB00B1CS9459 (+1 more)
LEI:
2138007U9P4BTZTYIR92
Country:
United Kingdom
Address:
EDEN RESEARCH PARK, CB6 1SE LITTLEPORT
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Cambridge Nutritional Sciences PLC is a specialist medical diagnostics company that develops, manufactures, and distributes diagnostic products for the food sensitivity testing market. The company promotes a personalized and functional approach to health, specializing in a range of tests associated with food sensitivity and gut health. Utilizing advanced diagnostic technology, it enables healthcare professionals and their patients to identify potential dietary and lifestyle changes to improve long-term wellbeing. As a pioneer in its field, the company leverages its expertise to provide tools for managing health through nutrition.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-25 17:30
Post-Annual General Meeting Information
Result of AGM
English 9.2 KB
2025-08-28 08:00
Report Publication Announcement
Notice of AGM & Annual Report
English 9.3 KB
2025-08-21 08:00
Remuneration Information
Grant of Options
English 17.1 KB
2025-08-19 08:00
Annual Report
Final Results
English 941.0 KB
2025-07-31 08:00
Report Publication Announcement
Notice of Results & Investor Presentation
English 13.8 KB
2025-07-10 08:00
Board/Management Information
Directorate Change
English 18.8 KB
2025-07-02 08:00
Major Shareholding Notification
Holding(s) in Company
English 22.2 KB
2025-05-27 08:00
Earnings Release
Trading Update
English 14.1 KB
2025-05-23 08:00
Legal Proceedings Report
Resolution on HSE Matter
English 13.5 KB
2025-03-19 08:00
Legal Proceedings Report
Omega Diagnostics Summons Update
English 12.1 KB
2025-03-18 15:48
Major Shareholding Notification
Holding(s) in Company
English 21.9 KB
2025-02-06 08:00
Director's Dealing
Director/PDMR Shareholding
English 30.7 KB
2025-01-30 10:41
Director's Dealing
Director/PDMR Shareholding
English 30.7 KB
2025-01-21 17:03
Legal Proceedings Report
Omega Diagnostics court summons
English 12.4 KB
2025-01-16 08:00
Legal Proceedings Report
Settlement of DHSC Claim
English 13.5 KB

Automate Your Workflow. Get a real-time feed of all CAMBRIDGE NUTRITIONAL SCIENCES PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CAMBRIDGE NUTRITIONAL SCIENCES PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.